NL-OMON27080尚未招募不适用
Pancreatic Cyst Follow-up, an International Collaboration, PACYFIC study<br>A prospective evaluation of pancreatic cyst surveillance, based on the consensus statement, formulated by the European study group on cystic tumours of the pancreas
Erasmus University Medical Center in Rotterdam, The Netherlands0 个研究点目标入组 5,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Individuals with a pancreatic cyst (either newly or previously diagnosed)
- •Cyst surveillance is warranted, according to the treating physician
排除标准
- •History of chronic pancreatitis
- •Suspected pseudocyst
研究者
相似试验
未知
不适用
Clinical Study, International, Multicentre, Prospective, Randomised, Interventional, and Controlled, Comparing Fresh Embryo Transfer (FET) Versus Elective Delayed Embryo Transfer (EDET), and Personalised Embryo Transfer (pET) Guided by the ERA (Endometrial Receptivity Array) Test as a Diagnostic Tool in Patients Treated by IVF/ICSI (in Vitro Fertilisation; Intra-cytoplasmic Sperm Injection)InfertilityJPRN-UMIN000022044Igenomix Headquarters, Parc Cientific. Univ. de Valencia546
已完成
不适用
OTUS: LOng-Term follow-Up Study of triple-negative breast cancerCancerBreast cancerTriple-negative breast cancerISRCTN43423520niversity of Leeds (UK)500
进行中（未招募）
不适用
Follow-up trial with no study drug prescription in diabetic patients previously included in the REGULATE trial.Type II diabetes The medical condition investigated in the REGULATE trial (CL3-00780-148) was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients.MedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001283-22-CZInstitut de Recherches Internationales Servier (I.R.I.S.)361
进行中（未招募）
不适用
Follow-up trial with no study drug prescription in diabetic patients previously included in the REGULATE trial.Type II diabetes The medical condition investigated in the REGULATE trial (CL3-00780-148) was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients.MedDRA version: 14.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001283-22-DEInstitut de Recherches Internationales Servier (I.R.I.S.)361
已完成
3 期
FOLLOW UP study for patients previously included in REGULATE study.CTRI/2011/11/002144Institut de recherches Internationales Servier845